SUBSCRIBE
SUBSCRIBE

TMX Newsfile

IN THE PRESS
Drug Development
Defence Therapeutics Prepares for Phase I Trial to Test Its DC Cancer Vaccine, AccuVAC-D002, Against Melanoma
October 6, 2021
 · 
3 min read
Psygen Announces That Psilocybin from Its Patent-Pending Process Has Been Used in Human Trial
October 6, 2021
 · 
4 min read
Telo Genomics Adopts Advanced Notice Provisions in By-Laws
October 5, 2021
 · 
4 min read
Pharm Country
Halberd’s VITASHIELDMAX(TM) Immunity Support Product Available on Amazon
October 5, 2021
 · 
3 min read
Pharm Country
Annovis Bio Announces Positive Phase 2 Efficacy Data for the Treatment of Parkinson’s Disease
October 5, 2021
 · 
6 min read
Deals
Awakn Life Sciences Announces Closing of Acquisition of Leading Ketamine-Assisted Psychotherapy Clinic in Norway
October 5, 2021
 · 
6 min read
Hemostemix Announces the Second Stem Cell Recipient Interview: One Week to No Chest Pain
October 4, 2021
 · 
7 min read
Advanced Proteome Therapeutics Technology Featured in Oral Presentation at the World Molecular Imaging Congress
October 4, 2021
 · 
5 min read
Business
CTI Announces New Lab Partnership With BioAgilytix
October 4, 2021
 · 
4 min read
Business
InFlectis BioScience Expands Leadership Team with Three Experienced International Appointments: Mark Pykett Is Appointed Chairman, Béatrice Lejeune Is Appointed Chief Regulatory Officer, and Prof. Brian Popko Joins Scientific Advisory Board
October 4, 2021
 · 
2 min read
Load More
15 Toronto St., Suite 601 Toronto ON M5C 2E3 US
Tel: 416-806-1750
Visit website
Email Us